SEARCH

SEARCH BY CITATION

References

  • Beking K, Vieira A (2010) Flavonoid intake and disability-adjuested life years due to Alzheimer's and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutr. 13, 14031409.
  • Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ (2013) C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer's disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity. J. Biol. Chem. 288, 654665.
  • Buczynski MW, Dumlao DS, Dennis EA (2009) An integrated omics analysis of eicosanoid biology. J. Lipid Res. 50, 10151038.
  • Butchart J, Holmes C (2012) Systemic and central immunity in Alzheimer's disease: therapeutic implications. CNS Neurosci. Ther. 18, 6476.
  • Chen Q, Prior M, Dargusch R, Roberts A, Riek R, Eichmann C, Chiruta C, Akaishi T, Abe K, Maher P, Schubert D (2011) A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease. PLoS One 6, e27865.
  • Choi YH, Lee SN, Aoyagi H, Yamasaki Y, Yoo JY, Park B, Shin DM, Yoon HG, Yoon JH (2011) The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling. J. Biol. Chem. 286, 3419934214.
  • Cortes-Canteli M, Paul J, Norris EH, Bronstein R, Ahn HJ, Zamolodchikov D, Bhuvanendran S, Fenz KM, Strickland S (2010) Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron 66, 695709.
  • Cruz JC, Tsai L-H (2004) Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol. Med. 10, 452458.
  • Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme J-S, Newell MK (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5, 118125.
  • Frautschy SA, Cole GM (2010) Why pleiotropic interventions are needed for Alzheimer's disease. Mol. Neurobiol. 41, 392409.
  • Gelderblom M, Leypoldt F, Lewerenz J, Birkenmayer G, Orozco D, Ludewig P, Thundyil J, Arumugam TV, Gerloff C, Tolosa E, Maher P, Magnus T (2012) The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice. J. Cereb. Blood Flow Metab. 32, 835843.
  • Giovannini MG, Cerbai F, Bellucci A, Melani C, Grossi C, Bartolozzi C, Nosi D, Casamenti F (2008) Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease. Neuroscience 153, 618633.
  • Giunta B, Rezai-Zadeh K, Tan J (2010) Impact of the CD40-CD40L dyad in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 9, 149155.
  • Golde TE, Schneider LS, Koo EH (2011) Anti-Abeta therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron 69, 203213.
  • Gulinello M, Gertner M, Mendoza G, Schoenfeld BP, Oddo S, LaFerla FM, Choi CH, McBride SMJ, Faber DS (2009) Validation of a 2-day water maze protocol in mice. Behav. Brain Res. 196, 220227.
  • Hardwick JP, Eckman K, Lee YK, Abdelmegeed MA, Esterle A, Chilian WM, Chiang JY, Song BJ (2013) Eicosanoids in metabolic syndrome. Adv. Pharmacol. 66, 157266.
  • Herrup K (2010) Reimagining Alzheimer's disease – an age-based hypothesis. J. Neurosci. 30, 1675516762.
  • Ishige K, Schubert D, Sagara Y (2001) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 30, 433446.
  • Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borshelt DR (2001) Co-Expression of multiple transgenes in mouse CNS: comparison of strategies. Biomol. Eng. 17, 157165.
  • Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH, Younkin SG, Borchelt DR, Savonenko AV (2005) Environmental enrichment mitigates cognitive defects in a mouse model of Alzheimer's disease. J. Neurosci. 25, 52175224.
  • Kesse-Guyot E, Fezeu L, Andreeva VA, Touvier M, Scalbert A, Herchberg S, Galan P (2011) Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later. J. Nutr. 142, 7683.
  • Kim H, Park B-S, Lee K-G, Choi CY, Jang SS, Kim Y-H, Lee S-E (2005) Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid. J. Agric. Food Chem. 53, 85378541.
  • Landreth GE, Reed-Geaghan EG (2009) Toll-like receptors in Alzheimer's disease. Curr. Top. Microbiol. Immunol. 336, 137153.
  • Lopes JP, Oliveira CR, Agostinho P (2010) Neurodegeneration in an Aβ-induced model of Alzheimer's disease: the role of Cdk5. Aging Cell 9, 6477.
  • Maher P (2009) Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin. Genes Nutr. 4, 297307.
  • Maher P, Akaishi T, Abe K (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc. Natl Acad. Sci. USA 103, 1656816573.
  • Maher P, Dargusch R, Bodai L, Gerard P, Purcell JM, Marsh JL (2011) ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Hum. Mol. Gen. 20, 261270.
  • Maron DM, Ames BN (1983) Revised method for the Salmonella mutagenicity test. Mutat. Res. 113, 173215.
  • Mohri I, Kadoyama K, Kanekiyo T, Sato Y, Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y, Maurayam S, Taniike M (2007) Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 66, 469480.
  • Muyllaert D, Terwel D, Kremer A, Sennvik K, Borghgraef P, Devijver H, Dewachter I, Van Leuven F (2008) Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice. Am. J. Pathol. 172, 470485.
  • Pugh PL, Richardson JC, Bate ST, Upton N, Sunter D (2007) Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav. Brain Res. 178, 1828.
  • Quehenberger O, Dennis EA (2011) The human plasma lipidome. N. Engl. J. Med. 365, 18121823.
  • Quehenberger O, Yamashita T, Armando AM, Dennis EA, Palinski W (2011) Effect of gestational hypercholesterolemia and maternal immunization on offspring plasma eicosanoids. Am. J. Obstet. Gynecol. 205, e15e25.
  • Rackoff J, Yang Q, DePetrillo PB (2001) Inhibition of rat PC12 cell calpain activity by glutathione, oxidized glutathione and nitric oxide. Neurosci. Lett. 311, 129132.
  • Rao JS, Rapoport SI, Kim H-W (2011) Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain. Transl. Psychiatry 1, e31.
  • Reynaud D, Thickitt CP, Pace-Asciak CR (1993) Facile preparation and structural determination of monohydroxy derivatives of docosahexaenoic acid (HDoHE) by alpha-tocopherol-directed autoxidation. Anal. Biochem. 214, 165170.
  • Sadleir KR, Vassar R (2012) Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism. J. Biol. Chem. 287, 72247235.
  • Sagara Y, Vahnnasy J, Maher P (2004) Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J. Neurochem. 90, 11441155.
  • Scher JU, Pillinger MH (2009) The anti-inflammatory effects of prostaglandins. J. Investig. Med. 57, 703708.
  • Schubert D, Maher P (2012) An alternative approach to drug discovery for Alzheimer's disease dementia. Future Med. Chem. 4, 16811688.
  • Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ (2008) Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic. Biol. Med. 45, 219230.
  • Steele ML, Robinson SR (2012) Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol. Aging 33, 423.e421–413.
  • Sundaram JR, Chan ES, Poore CP, Pareek TK, Cheong WF, Shui G, Tang N, Low CM, Wenk MR, Kesavapany S (2012) Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J. Neurosci. 32, 10201034.
  • Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 14, 311317.
  • Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1, 848858.
  • Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 311328.
  • Wirths O, Breyhan H, Marcello A, Cotel M-C, Bruck W, Bayer TA (2010) Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease. Neurobiol. Aging 31, 747757.
  • Yoon HJ, Jeon SB, Kim IH, Park EJ (2008) Regulation of TLR2 expression by prostaglandins in brain glia. J. Immunol. 180, 84008409.